Todays rise is undoubtedly due to J.P.Morgan...
Real-time equity news
U.S. stock market report 0851 EST 22Feb2010-JPMorgan starts Dendreon at "overweight"
J.P. Morgan started coverage of Dendreon Corp with an "overweight" rating saying the company's experimental prostate cancer vaccine has a 90 percent chance of getting regulatory approval by its review date of May 1.
In a research note to clients, analyst Cory Kasimov said a survey of 53 physicians done by the brokerage suggested a relatively broad adoption of the vaccine, Provenge, upon approval and supports a blockbuster market opportunity.
dndn, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 30.5¢ | $251.5K | 806.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 121215 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 2864 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |